Authors: Hainsworth, JD Burris, HA Calvert, SW Willcutt, NT Scullin, DC Bramham, J Greco, FA

Citation: Jd. Hainsworth et al., Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: A phase II trial of the Minnie Pearl Cancer Research Network, CANCER INV, 19(4), 2001, pp. 335-339

Authors: Burris, HA Hainsworth, JD Erland, JB Morrissey, LH Kalman, LA Hon, JK Scullin, DC Smith, SW Greco, FA

Citation: Ha. Burris et al., Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancer, SEMIN ONCOL, 27(1), 2000, pp. 9-13

Authors: Hainsworth, JD Burris, HA Morrissey, LH Litchy, S Scullin, DC Bearden, JD Richards, P Greco, FA

Citation: Jd. Hainsworth et al., Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma, BLOOD, 95(10), 2000, pp. 3052-3056

Authors: Hainsworth, JD Burris, HA Erland, JB Morrissey, LH Meluch, AA Kalman, LA Hon, JK Scullin, DC Smith, SW Greco, FA

Citation: Jd. Hainsworth et al., Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma, CANCER, 85(6), 1999, pp. 1269-1276